Market News Archives

Tesla’s Robotaxi Gamble: Stock Surges as Cars Ditch Safety Drivers -( $TSLA $SPY )

by Vista Partners LLC December 15, 2025 627Views 0Likes

Tesla’s (TSLA) stock pop on the latest robotaxi milestone reads less like a traditional product update and more like the opening scene of a market fable: a trillion‑dollar carmaker, a driverless SUV ghosting around Austin, and a CEO insisting the future has…

How Nokia and Airtel Aim to Monetize 5G APIs and Rewrite India’s Enterprise Playbook – ( $NOK )

by Vista Partners LLC December 14, 2025 643Views 0Likes

Nokia’s (NOK) latest deal with Bharti Airtel is less a routine vendor announcement than a reminder that in 5G, the real money may lie not in more base stations, but in turning the network itself into something closer to a programmable asset…

Record Highs for Dow and S&P 500: Eli Lilly Shines, Oracle Sinks AI Sentiment This Week – December 12, 2025 -( $LLY $MCD $NOK $PL $PLTR $RIO $TSLA Rise!)

by Vista Partners LLC December 12, 2025 2419Views 0Likes

Wall Street limped into the weekend looking like a marathoner who realized the finish line had quietly moved 100 yards farther away: still standing, but with the AI high-fliers suddenly short of breath and old‑economy cyclicals enjoying a late‑season second wind. Indexes:…

From Pixels to Profits: Planet Labs Turns Satellite Imagery into a Down-to-Earth Cash Machine -( $PL $NFLX )

by Vista Partners LLC December 12, 2025 613Views 0Likes

Planet Labs (NYSE: PL) just delivered the kind of quarter that makes even jaded space investors sit up straighter, with revenue blasting past expectations and guidance pointing to a company finally acting like a real business instead of a science project in…

Eupraxia Pharmaceuticals: The Small‑Cap Biotech Quietly Seeking To Build a Billion‑Dollar Plus EoE Franchise -( $EPRX $IBB $XBI )

by Vista Partners LLC December 12, 2025 833Views 0Likes

Eupraxia Pharmaceuticals (NASDAQ: EPRX, $6.40, +1.59% today and +85.51% over the last year) is emerging as a standout small‑cap biotech, transforming a once‑niche GI indication and routine endoscopy visits into a compelling, scalable growth platform, underpinned by a mid‑teens price target from…

Dow and S&P 500 Hit New Highs While Tech Wobbles: Tariffs, Fed Cuts, and IPOs Shape December 11, 2025 Trading -( $EPRX $LMRI $MODD $NOK $OKLO $OPEN $PL $RIO $SOAR Rise!)

by Vista Partners LLC December 11, 2025 2344Views 0Likes

Wall Street ended Thursday with the Dow and S&P 500 looking like they’d just discovered compound interest, while the Nasdaq nursed an AI hangover and small caps quietly joined the advance. The Dow Jones Industrial Average surged about 1.3% to a fresh…

Modular Medical Bets on ~$3B Market for “Almost-Pumpers,” Taps Wall Street to Fuel Next-Gen Insulin Patch Pumps -( $MODD )

by Vista Partners LLC December 11, 2025 909Views 0Likes

In a season when most micro-cap CEOs are more focused on keeping the lights on than rewriting the diabetes playbook, Modular Medical (MODD) is trying to do both – and pass the hat on Wall Street at the same time. The San…

GE Vernova Doubles Dividend: How a New Energy Powerhouse Just Joined Wall Street’s Cash‑Return Elite -( $GEV $SPY )

by Vista Partners LLC December 11, 2025 787Views 0Likes

GE Vernova’s (NYSE: GEV) decision to double its quarterly dividend for early 2026 reads less like a routine board action and more like a coming‑of‑age announcement from Wall Street’s newest power broker in the energy transition trade. In a market where “capital…

Rate Cuts, Curves and Chips: How the Fed’s Quarter-Point Trim Reshaped Wednesday’s Tape – December 10, 2025 -( $AAPL $ABVX $AVGO $DV $EPRX $INTC $INTG $LLY $NOK $PLTR $RIO $TSLA $TSM Rise!)

by Vista Partners LLC December 10, 2025 2098Views 0Likes

Markets leaned into the Fed’s latest cut with the kind of cautious enthusiasm usually reserved for a long‑overdue bonus. Major indexes U.S. stocks spent Wednesday strutting rather than sprinting, as the S&P 500 rose about 0.7% to roughly 6,887, just shy of…

Inside GeoVax’s Big-League Scientific Upgrade: Global Experts Join the Fight Against Cancer and Deadly Viruses -( $GOVX $AZN $IBB $XBI )

by Vista Partners LLC December 10, 2025 734Views 0Likes

GeoVax’s (NASDAQ: GOVX) latest boardroom move reads like a biotech who’s-who casting call, with the Atlanta-based vaccine developer quietly assembling a scientific brain trust that looks less like a small-cap advisory board and more like a Davos side panel on immunology. A…

Market News

Your Guide To Staying Informed In The Markets